Key facts
- This page summarizes Matthew P. Miller's Form 4 filing for Oncology Institute, Inc. (TOI).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 21 Mar 2023, 20:56.
Matthew P. Miller - 17 Mar 2023 Form 4 Insider Report for Oncology Institute, Inc. (TOI)
- Reporting relationship
- Chief Operating Officer
- Issuer ticker
- TOI
- Reported as of
- 17 Mar 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 21 Mar 2023, 20:56:03 UTC
- Prior SEC filing
- 20 Dec 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Mark Hueppelsheuser, Attorney-in-Fact for Matthew P Miller
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Matthew P. Miller filed Form 4 for Oncology Institute, Inc. (TOI) on 21 Mar 2023.
Change
- Previous filing in this sequence was filed on 20 Dec 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TOI
transaction
Common stock
Award
- Transaction value
- $0
- Shares
- +67,667
- Change %
- +39%
- Price
- $0.000000
- Shares after
- 242,992
- Date
- 17 Mar 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TOI
transaction
Derivative
Non-Qualified Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +169,169
- Change %
- Price
- $0.000000
- Shares after
- 169,169
- Date
- 17 Mar 2023
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
- 169,169
- Exercise price
- $0.4810
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents RSUs with 1/4th of the RSUs vesting on the anniversary of March 17, 2023 (the Vesting Commencement Date), with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.
Footnote F2
The stock options vest as to 1/4th of the options granted on the first anniversary of the Vesting Commencement Date, with the remaining options vesting in four equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all options becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.